PDCD1 and tongue neoplasm: In mEER tongue tumors sensitive to α-PD-1 therapy, we observed an enhanced IFN gene expression signature (both type I and type II), and higher PD-1 levels on CD8+ TIL compared to the resistant flank tumors.